Cargando…

Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein

BACKGROUND: Parkinson’s disease is an age-related disease whose pathogenesis is not completely known. Animal models exist for investigating the disease but not all results can be easily transferred to humans. Therefore, mathematical or probabilistic models for the human disease are to be constructed...

Descripción completa

Detalles Bibliográficos
Autores principales: Büchel, Finja, Saliger, Sandra, Dräger, Andreas, Hoffmann, Stephanie, Wrzodek, Clemens, Zell, Andreas, Kahle, Philipp J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871002/
https://www.ncbi.nlm.nih.gov/pubmed/24195591
http://dx.doi.org/10.1186/1471-2202-14-136
_version_ 1782296756361363456
author Büchel, Finja
Saliger, Sandra
Dräger, Andreas
Hoffmann, Stephanie
Wrzodek, Clemens
Zell, Andreas
Kahle, Philipp J
author_facet Büchel, Finja
Saliger, Sandra
Dräger, Andreas
Hoffmann, Stephanie
Wrzodek, Clemens
Zell, Andreas
Kahle, Philipp J
author_sort Büchel, Finja
collection PubMed
description BACKGROUND: Parkinson’s disease is an age-related disease whose pathogenesis is not completely known. Animal models exist for investigating the disease but not all results can be easily transferred to humans. Therefore, mathematical or probabilistic models for the human disease are to be constructed in silico in order to predict specific processes within a cell, such as the dopamine metabolism and transport processes in a neuron. RESULTS: We present a Systems Biology Markup Language (SBML) model of a whole dopaminergic nerve cell consisting of 139 reactions and 111 metabolites which includes, among others, the dopamine metabolism and transport, oxidative stress, aggregation of α-synuclein (αSYN), lysosomal and proteasomal degradation, and mitophagy. The predictive power of the model was investigated using flux balance analysis for the identification of steady model states. To this end, we performed six experiments: (i) investigation of the normal cell behavior, (ii) increase of O(2), (iii) increase of ATP, (iv) influence of neurotoxins, (v) increase of αSYN in the cell, and (vi) increase of dopamine synthesis. The SBML model is available in the BioModels database with identifier MODEL1302200000. CONCLUSION: It is possible to simulate the normal behavior of an in vivo nerve cell with the developed model. We show that the model is sensitive for neurotoxins and oxidative stress. Further, an increased level of αSYN induces apoptosis and an increased flux of αSYN to the extracellular space was observed.
format Online
Article
Text
id pubmed-3871002
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38710022013-12-27 Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein Büchel, Finja Saliger, Sandra Dräger, Andreas Hoffmann, Stephanie Wrzodek, Clemens Zell, Andreas Kahle, Philipp J BMC Neurosci Research Article BACKGROUND: Parkinson’s disease is an age-related disease whose pathogenesis is not completely known. Animal models exist for investigating the disease but not all results can be easily transferred to humans. Therefore, mathematical or probabilistic models for the human disease are to be constructed in silico in order to predict specific processes within a cell, such as the dopamine metabolism and transport processes in a neuron. RESULTS: We present a Systems Biology Markup Language (SBML) model of a whole dopaminergic nerve cell consisting of 139 reactions and 111 metabolites which includes, among others, the dopamine metabolism and transport, oxidative stress, aggregation of α-synuclein (αSYN), lysosomal and proteasomal degradation, and mitophagy. The predictive power of the model was investigated using flux balance analysis for the identification of steady model states. To this end, we performed six experiments: (i) investigation of the normal cell behavior, (ii) increase of O(2), (iii) increase of ATP, (iv) influence of neurotoxins, (v) increase of αSYN in the cell, and (vi) increase of dopamine synthesis. The SBML model is available in the BioModels database with identifier MODEL1302200000. CONCLUSION: It is possible to simulate the normal behavior of an in vivo nerve cell with the developed model. We show that the model is sensitive for neurotoxins and oxidative stress. Further, an increased level of αSYN induces apoptosis and an increased flux of αSYN to the extracellular space was observed. BioMed Central 2013-11-06 /pmc/articles/PMC3871002/ /pubmed/24195591 http://dx.doi.org/10.1186/1471-2202-14-136 Text en Copyright © 2013 Büchel et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Büchel, Finja
Saliger, Sandra
Dräger, Andreas
Hoffmann, Stephanie
Wrzodek, Clemens
Zell, Andreas
Kahle, Philipp J
Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title_full Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title_fullStr Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title_full_unstemmed Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title_short Parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
title_sort parkinson’s disease: dopaminergic nerve cell model is consistent with experimental finding of increased extracellular transport of α-synuclein
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871002/
https://www.ncbi.nlm.nih.gov/pubmed/24195591
http://dx.doi.org/10.1186/1471-2202-14-136
work_keys_str_mv AT buchelfinja parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT saligersandra parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT dragerandreas parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT hoffmannstephanie parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT wrzodekclemens parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT zellandreas parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein
AT kahlephilippj parkinsonsdiseasedopaminergicnervecellmodelisconsistentwithexperimentalfindingofincreasedextracellulartransportofasynuclein